104
Participants
Start Date
February 6, 2019
Primary Completion Date
January 31, 2020
Study Completion Date
February 29, 2020
Training
The training includes of (1) in-person training with pre- and post-session knowledge and attitude assessment, (2) three month post-session knowledge and attitude assessment and (3) self-report of first-time buprenorphine-naloxone Emergency Department (ED) administration within 3 month study period
Behavioral economic enhanced arm
Behavioral economic enhancement includes an opt-out invitation, loss-framed incentivization, weekly tailored text based reminders
University of Pennsylvania Health System, Philadelphia
American College of Medical Toxicology
OTHER
Blue Cross Blue Shield
OTHER
University of Pennsylvania
OTHER